Offer also includes seven-year warrants; Monarch Capital is the agent
By Devika Patel
Knoxville, Tenn., April 21 - Gulfstream International Group, Inc. settled a second $500,000 tranche of a $5 million private placement of 9% subordinated convertible promissory notes on April 15, according to an 8-K filed Thursday with the Securities and Exchange Commission. The company sold $1.3 million of notes on Feb. 28.
The one-year note is initially convertible into common shares at $0.30 per share, which represents a 28.57% discount to $0.42, the Feb. 25 closing share price.
The investors also received seven-year warrants for 1,916,664 common shares in the first tranche and warrants for 833,332 shares in the second as part of the deal's 50% warrant coverage. The warrants are each exercisable at $0.30, also a 28.57% discount to the Feb. 25 closing share price.
The ongoing placement is expected to settle July 31; it is being conducted by Monarch Capital Group LLC. SAIL Venture Partners, LP bought all $500,000 of the notes in the second tranche.
Based in Costa Mesa, Calif., CNS Response develops and commercializes new indications of approved drugs and drug candidates.
Issuer: | CNS Response, Inc.
|
Issue: | Secured convertible promissory notes
|
Amount: | $5 million
|
Maturity: | One year
|
Coupon: | 9%
|
Conversion price: | $0.30
|
Warrants: | 50% coverage
|
Warrant expiration: | Seven years
|
Warrant strike price: | $0.30
|
Agent: | Monarch Capital Group LLC
|
Investor: | SAIL Venture Partners, LP (for $500,000)
|
Settlement date: | Feb. 28 (for $1.3 million), April 15 (for $500,000)
|
Stock symbol: | OTCBB: CNSO
|
Stock price: | $0.30 at close Feb. 28
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.